US Patent Issued to BIOGAIA on June 3 for "Faecalibacterium prausnitzii and Desulfovibrio piger for use in the treatment or prevention of diabetes and bowel diseases" (Swedish Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,412, issued on June 3, was assigned to BIOGAIA AB (Stockholm).

"Faecalibacterium prausnitzii and Desulfovibrio piger for use in the treatment or prevention of diabetes and bowel diseases" was invented by Muhammad-Tanweer Khan (Molndal, Sweden) and Fredrik Backhed (Kullavik, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates generally to medicine. More specifically the invention relates to the use of synergistic probiotic bacteria as intervention for health.In particular, the present invention provides a strain of Faecalibacterium prausnitzii and a bacterial strain which has one or more of the characteristics of: (i) b...